Dumontet C - Search Results

1

Review of recent studies on resistance to cytotoxic deoxynucleoside analogues.

Jordheim LP, Dumontet C. Jordheim LP, et al. Among authors: dumontet c. Biochim Biophys Acta. 2007 Dec;1776(2):138-59. doi: 10.1016/j.bbcan.2007.07.004. Epub 2007 Aug 14. Biochim Biophys Acta. 2007. PMID: 17881132 Review.

2

[Metabolism, mechanism of action and resistance to cytotoxic nucleoside analogues].

Jordheim LP, Galmarini CM, Dumontet C. Jordheim LP, et al. Among authors: dumontet c. Bull Cancer. 2005 Mar;92(3):239-48. Bull Cancer. 2005. PMID: 15820918 Free article. Review. French.

3

Increased expression of the large subunit of ribonucleotide reductase is involved in resistance to gemcitabine in human mammary adenocarcinoma cells.

Jordheim LP, Guittet O, Lepoivre M, Galmarini CM, Dumontet C. Jordheim LP, et al. Among authors: dumontet c. Mol Cancer Ther. 2005 Aug;4(8):1268-76. doi: 10.1158/1535-7163.MCT-05-0121. Mol Cancer Ther. 2005. PMID: 16093443

4

Gemcitabine resistance due to deoxycytidine kinase deficiency can be reverted by fruitfly deoxynucleoside kinase, DmdNK, in human uterine sarcoma cells.

Jordheim LP, Galmarini CM, Dumontet C. Jordheim LP, et al. Among authors: dumontet c. Cancer Chemother Pharmacol. 2006 Oct;58(4):547-54. doi: 10.1007/s00280-006-0195-8. Epub 2006 Feb 4. Cancer Chemother Pharmacol. 2006. PMID: 16463058

5

Recent developments to improve the efficacy of cytotoxic nucleoside analogues.

Jordheim LP, Galmarini CM, Dumontet C. Jordheim LP, et al. Among authors: dumontet c. Recent Pat Anticancer Drug Discov. 2006 Jun;1(2):163-70. doi: 10.2174/157489206777442205. Recent Pat Anticancer Drug Discov. 2006. PMID: 18221034 Review.

6

Drug resistance to cytotoxic nucleoside analogues.

Jordheim L, Galmarini CM, Dumontet C. Jordheim L, et al. Among authors: dumontet c. Curr Drug Targets. 2003 Aug;4(6):443-60. doi: 10.2174/1389450033490957. Curr Drug Targets. 2003. PMID: 12866659 Review.

7

Development of gene therapy in association with clinically used cytotoxic deoxynucleoside analogues.

Hébrard C, Dumontet C, Jordheim LP. Hébrard C, et al. Among authors: dumontet c. Cancer Gene Ther. 2009 Jul;16(7):541-50. doi: 10.1038/cgt.2009.25. Epub 2009 Apr 3. Cancer Gene Ther. 2009. PMID: 19343063 Review.

8

Role of IMP-selective 5'-nucleotidase (cN-II) in hematological malignancies.

Galmarini CM, Jordheim L, Dumontet C. Galmarini CM, et al. Among authors: dumontet c. Leuk Lymphoma. 2003 Jul;44(7):1105-11. doi: 10.1080/1042819031000077142. Leuk Lymphoma. 2003. PMID: 12916861 Review.

9

Problems related to resistance to cytarabine in acute myeloid leukemia.

Cros E, Jordheim L, Dumontet C, Galmarini CM. Cros E, et al. Among authors: dumontet c. Leuk Lymphoma. 2004 Jun;45(6):1123-32. doi: 10.1080/1042819032000159861. Leuk Lymphoma. 2004. PMID: 15359991 Review.

10

F-ara-AMP is a substrate of cytoplasmic 5'-nucleotidase II (cN-II): HPLC and NMR studies of enzymatic dephosphorylation.

Jordheim LP, Cros E, Galmarini CM, Dumontet C, Bretonnet AS, Krimm I, Lancelin JM, Gagnieu MC. Jordheim LP, et al. Among authors: dumontet c. Nucleosides Nucleotides Nucleic Acids. 2006 Mar;25(3):289-97. doi: 10.1080/15257770500458027. Nucleosides Nucleotides Nucleic Acids. 2006. PMID: 16629121

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

403 results

Search Page

Filters